Delcath Systems Inc.
Organization details
- Legal name
- Delcath Systems Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 3841 — Surgical & Medical Instruments & Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Queensbury
- Headquarters state / province
- New York
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- DCTH
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0000872912
- EIN
- 06-1245881
- Wikidata ID
- Q5253556
Board of directors
-
Bridget A. Martell · DirectorSince 2024
-
Elizabeth Czerepak · DirectorSince 2023
-
Gerard J. Michel · Director · CHIEF EXECUTIVE OFFICERSince 2023
-
Gil Aharon · DirectorSince 2023
-
John Richard Sylvester · DirectorSince 2023
-
Roger G. Stoll Ph.D. · DirectorSince 2023
-
Steven A. J. Salamon · DirectorSince 2023
Chief executives
Director election results
Annual meeting of May 13, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
96.5%
-
97.0%
Board connections
4 of this board's directors also sit on 5 other boards. 5 are in the same sector.
-
Achieve Life Sciences Inc. Same sectorvia Bridget A. Martell
-
Aligos Therapeutics Inc. Same sectorvia Bridget A. Martell
-
Beta Bionics Inc. Same sectorvia Gerard J. Michel
-
Neuraxis Inc. Same sectorvia Gil Aharon
-
TransCode Therapeutics Inc. Same sectorvia Elizabeth Czerepak
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $189,362
- 3 purchases by 3 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 6, 2026 | Pennell Sandra Officer (Chief Financial Officer) | Open-market purchase | +5,533 | $9.04 | $50,018 |
| Mar 2, 2026 | Gerard J. Michel Director, Officer (CHIEF EXECUTIVE OFFICER) | Open-market purchase | +11,200 | $8.96 | $100,352 |
| Nov 21, 2025 | John Richard Sylvester Director | Open-market purchase | +4,386 | $8.89 | $38,992 |
| Nov 11, 2025 | Gerard J. Michel Director, Officer (CHIEF EXECUTIVE OFFICER) | Open-market purchase | +11,500 | $8.53 | $98,095 |
| Jun 12, 2025 | Vukovic Vojo Officer (CHIEF MEDICAL OFFICER) | Option exercise | +42,000 | $4.78 | $200,760 |
| May 5, 2025 | Gil Aharon Director | In-the-money exercise | +400,000 | $10.00 | $4,000,000 |
| May 5, 2025 | Steven A. J. Salamon Director | In-the-money exercise | +400,000 | $10.00 | $4,000,000 |
| May 5, 2025 | Steven A. J. Salamon Director | In-the-money exercise | +400,000 | $10.00 | $4,000,000 |
| Dec 24, 2024 | Steven A. J. Salamon Director | Derivative conversion | +250,000 | $10.00 | $2,500,000 |
| Dec 24, 2024 | Gil Aharon Director | Derivative conversion | +250,000 | $10.00 | $2,500,000 |
| Dec 24, 2024 | Rosalind Advisors, Inc. Director | Derivative conversion | +250,000 | $10.00 | $2,500,000 |
| Oct 22, 2024 | Gerard J. Michel Director, Officer (CHIEF EXECUTIVE OFFICER) | Option exercise | +16,666 | $6.00 | $99,996 |
| Apr 18, 2024 | Gil Aharon Director | In-the-money exercise | +619,946 | $6,199.46 | $3,843,330,429 |
| Apr 18, 2024 | Steven A. J. Salamon Director | Derivative conversion | +991,615 | — | — |
| Apr 18, 2024 | Rosalind Advisors, Inc. Director | In-the-money exercise | +619,946 | $6,199.46 | $3,843,330,429 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Delcath Systems Inc.
Who is the CEO of Delcath Systems Inc.?
Gerard J. Michel is Delcath Systems Inc.'s Chief Executive Officer.
How many directors are on Delcath Systems Inc.'s board?
Delcath Systems Inc.'s board has 7 directors: Bridget A. Martell, Elizabeth Czerepak, Gerard J. Michel, Gil Aharon, John Richard Sylvester, Roger G. Stoll Ph.D. and Steven A. J. Salamon.
Are Delcath Systems Inc. insiders buying or selling shares?
Over the last 12 months, Delcath Systems Inc. insiders bought $189,362 of shares in 3 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="delcath-systems-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.